Igc Pharma Inc. has reported results of preclinical studies investigating TGR-63 as a treatment for Alzheimer’s disease, showing enhanced memory function in an Alzheimer’s mouse model, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback